MVP Promotes Intrinsic Conduction

In Patients with sinus node dysfunction:

• When ventricular pacing is less than 40%, for each 10% increase in ventricular pacing there is a 54% relative increase in risk for heart failure hospitalization.¹
• When ventricular pacing is greater than 40% a patient's relative risk for heart failure hospitalization remains constant.¹
• The risk of atrial fibrillation increases linearly as the percentage of ventricular pacing increases from 0% to 85%.¹

Click to enlarge

Click to enlarge

Promoting Intrinsic Conduction Without Compromising Safety

Managed Ventricular Pacing (MVP™) is an atrial-based pacing mode that significantly reduces unnecessary right ventricular pacing ^1,2 by primarily operating in an AAI(R) pacing mode while providing the safety of a dual chamber backup mode if necessary.

Click to enlarge

Click here to view the MVP Mode Operation video (3:49)

References

1. Sweeney M, Hellkamp A, Ellenbogen K, et al, for the MOde Selection Trial (MOST) Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003;107:2932-2937.

2. Gillis AM et al, Reduction of Unnecessary Right Ventricular Pacing due to the Managed Ventricular Pacing (MVP) Mode in Patients with Symptomatic Bradycardia: Benefit for Both Sinus Node Disease and AV Block Indications. HRS. 2005 Abstract; AB21-1.

©Medtronic, Inc. 2008                                                   • Contact Medtronic • Privacy Statement • Terms of Use • Site Map